Overall Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma-Reference-Cited by-同舟云学术

Overall Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma

Published:2017-10-05 Issue:14 Volume:377 Page:1345-1356
ISSN:0028-4793
Container-title:New England Journal of Medicine
language:en
Short-container-title:N Engl J Med

Author:

Wolchok Jedd D.¹,Chiarion-Sileni Vanna¹,Gonzalez Rene¹,Rutkowski Piotr¹,Grob Jean-Jacques¹,Cowey C. Lance¹,Lao Christopher D.¹,Wagstaff John¹,Schadendorf Dirk¹,Ferrucci Pier F.¹,Smylie Michael¹,Dummer Reinhard¹,Hill Andrew¹,Hogg David¹,Haanen John¹,Carlino Matteo S.¹,Bechter Oliver¹,Maio Michele¹,Marquez-Rodas Ivan¹,Guidoboni Massimo¹,McArthur Grant¹,Lebbé Celeste¹,Ascierto Paolo A.¹,Long Georgina V.¹,Cebon Jonathan¹,Sosman Jeffrey¹,Postow Michael A.¹,Callahan Margaret K.¹,Walker Dana¹,Rollin Linda¹,Bhore Rafia¹,Hodi F. Stephen¹,Larkin James¹

Affiliation:

1. From the Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York (J.D.W., M.A.P., M.K.C.); Oncology Institute of Veneto Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Padua (V.C.-S.), European Institute of Oncology, Milan (P.F.F.), Center for Immuno-Oncology, University Hospital of Siena, Istituto Toscano Tumori, Siena (M.M.), the Immunotherapy and Somatic Cell Therapy Unit, IRCCS Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori, Meldola (M.G.),...

Publisher

Massachusetts Medical Society

Subject

General Medicine

Link

http://www.nejm.org/doi/pdf/10.1056/NEJMoa1709684

Cited by 2781 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dawn era for revisited cancer therapy by innate immune system and immune checkpoint inhibitors;Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease;2024-03

2. Effects of CTLA-4 Single Nucleotide Polymorphisms on Toxicity of Ipilimumab-Containing Regimens in Patients With Advanced Stage Melanoma;Journal of Immunotherapy;2024-02-06

3. Tumor-infiltrating lymphocytes as a prognostic and predictive factor for Melanoma;Expert Review of Molecular Diagnostics;2024-02-05

4. Diagnosing and Managing Uveitis Associated with Immune Checkpoint Inhibitors: A Review;Diagnostics;2024-02-04

5. Concentrations of S100B and neurofilament light chain in blood as biomarkers for checkpoint inhibitor–induced CNS inflammation;eBioMedicine;2024-02